Map movement mood and sleep
- Trial ID
- NCT06536348
- Official Title
- PARKINSON BRASIL - Database on Motor and Non-Motor Aspects of Parkinson's Disease in Brazil
- Goal
- Map movement mood and sleep
- Status
- RECRUITING
- Sponsor
- Federal University of Uberlandia
- Study Type
- OBSERVATIONAL
- Enrollment
- 958 participants
- Conditions
- Parkinson Disease
Summary For Families
The project is building a large Brazilian database to map motor and non-motor features of Parkinson's disease, so doctors and researchers can better track symptoms, find patterns, and improve care and future studies. It does this by collecting clinical assessments and tests, recording movement exam results plus non-motor issues like mood, sleep and thinking, and includes vision screening, without testing any experimental drug or device. Participants need to have central visual acuity of at least 20/40 in each eye or 20/30 in one eye because good vision is required for the tests. The study is open to adults 18 to 120, enrolling people with a neurologist-confirmed PD diagnosis at Hoehn and Yahr stages I to IV and control volunteers without PD or similar neurological diseases, while excluding anyone with other neurological or musculoskeletal problems that would prevent testing.
Locations
- Laboratório de Análise de Movimento e Processamento de Sinais, Brasília, Federal District, Brazil
- Centro Universitário Araguaia (UniAraguaia), Goiânia, Goiás, Brazil
- Associação Parkinson Goiás, Goiânia, Goiás, Brazil
- Ambulatório de Doença de Parkinson e Distúrbios do Movimento do Hospital de Clínicas de Uberlândia, Uberlândia, Minas Gerais, Brazil
- Núcleo de Inovação e Avaliação Tecnológica em Saúde / Centre for Innovation and Technology Assessment in Health, Uberlândia, Minas Gerais, Brazil
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The project is building a large Brazilian database to map motor and non-motor features of Parkinson's disease, so doctors and researchers can better track symptoms, find patterns, and improve care and future studies. It does this by collecting clinical assessments and tests, recording movement exam results plus non-motor issues like mood, sleep and thinking, and includes vision screening, without testing any experimental drug or device. Participants need to have central visual acuity of at least 20/40 in each eye or 20/30 in one eye because good vision is required for the tests. The study is open to adults 18 to 120, enrolling people with a neurologist-confirmed PD diagnosis at Hoehn and Yahr stages I to IV and control volunteers without PD or similar neurological diseases, while excluding anyone with other neurological or musculoskeletal problems that would prevent testing.
- Who can participate?
- Participants must be between 18 Years and 120 Years.
- Where is this trial located?
- This trial is recruiting at 5 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 9 years and 9 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.